Hanmi Pharm. Co., Ltd.
128940
Rangering i aksjer
#4358
A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was... A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was established in Seoul, South Korea, in 1973. The firm concentrates its efforts on researching and developing medical therapies for a range of health issues, including diabetes, obesity, cancer, autoimmune disorders, and various rare diseases.
Aksjekurs
$279.16
Markedsverdi
$3.54B
Endring (1 dag)
-2.37%
Endring (1 år)
14.50%
Land
KR
Handel Hanmi Pharm. Co., Ltd. (128940)
Kategori
Healthcare
Utbytteavkastning for Hanmi Pharm. Co., Ltd. (128940)
Hanmi Pharm. Co., Ltd. (aksjesymbol: 128940) sin utbytteavkastning (TTM) per 2024-12-31 er: 0.35%
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.32%
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.32%
Utbytteavkastning for Hanmi Pharm. Co., Ltd. (128940) fra 2010 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
| År | Utbytteavkastning | Endre |
|---|---|---|
| 2026 (TTM) | 0.54% | 1.89% |
| 2025 | 0.53% | 51.43% |
| 2024 | 0.35% | -12.50% |
| 2023 | 0.40% | 150.00% |
| 2022 | 0.16% | -5.88% |
| 2021 | 0.17% | -10.53% |
| 2020 | 0.19% | 18.75% |
| 2019 | 0.16% | -11.11% |
| 2018 | 0.18% | 125.00% |
| 2017 | 0.08% | -88.57% |
| 2016 | 0.70% | 159.26% |
| 2015 | 0.27% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | -100.00% |
| 2011 | 0.03% | 0.00% |
| 2010 | 0.00% | 0.00% |
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
| Selskap | Utbytteavkastning | Land |
|---|---|---|
| 1.63% |
DE
|
|
| 1.50% |
DE
|
|
| 3.18% |
JP
|
|
| 0.19% |
CH
|
|
| 0.91% |
IN
|
